null

SMILES: Cc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C(N)=O)c(C)c1

InChI Key: InChIKey=PZTCWIODTRRXCQ-XMMPIXPASA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454199   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454199 (US10717708, Example 175 | US11186544, Example 175) Show SMILES Cc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C(N)=O)c(C)c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-17-9-14-23(18(2)16-17)29-27(34)30-24-8-5-15-31(26(24)33)20-12-10-19(11-13-20)21-6-3-4-7-22(21)25(28)32/h3-4,6-7,9-14,16,24H,5,8,15H2,1-2H3,(H2,28,32)(H2,29,30,34)/t24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	520	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454199 (US10717708, Example 175 | US11186544, Example 175) Show SMILES Cc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C(N)=O)c(C)c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-17-9-14-23(18(2)16-17)29-27(34)30-24-8-5-15-31(26(24)33)20-12-10-19(11-13-20)21-6-3-4-7-22(21)25(28)32/h3-4,6-7,9-14,16,24H,5,8,15H2,1-2H3,(H2,28,32)(H2,29,30,34)/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	2.60E+3	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454199 (US10717708, Example 175 | US11186544, Example 175) Show SMILES Cc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C(N)=O)c(C)c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-17-9-14-23(18(2)16-17)29-27(34)30-24-8-5-15-31(26(24)33)20-12-10-19(11-13-20)21-6-3-4-7-22(21)25(28)32/h3-4,6-7,9-14,16,24H,5,8,15H2,1-2H3,(H2,28,32)(H2,29,30,34)/t24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	520	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454199 (US10717708, Example 175 | US11186544, Example 175) Show SMILES Cc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2C(N)=O)c(C)c1 |r| Show InChI InChI=1S/C27H28N4O3/c1-17-9-14-23(18(2)16-17)29-27(34)30-24-8-5-15-31(26(24)33)20-12-10-19(11-13-20)21-6-3-4-7-22(21)25(28)32/h3-4,6-7,9-14,16,24H,5,8,15H2,1-2H3,(H2,28,32)(H2,29,30,34)/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.60E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair